Virus News and Research

Latest Virus News and Research

Impact of SARS-CoV-2 variants in unvaccinated and vaccinated U.S. military personnel

A new study helps to explain the rapid spread of the Delta variant and provides the impetus to increase control measures including vaccine boosters and social distancing requirements.

20 Dec 2021

Humanized mice reveals why few COVID-19 cases are more severe than others

Why do 80 to 90% of people infected with COVID-19 experience only mild cases while 10 to 20% face more severe or life-threatening symptoms?

20 Dec 2021

REACT-1 study shows COVID boosters and first doses in children are providing important protection

The Real-time Assessment of Community Transmission-1 (REACT-1) study has been tracking the transmission of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) throughout England since May 2020. SARS-CoV-2 is the cause of the ongoing coronavirus disease 2019 (COVID-19) pandemic.

19 Dec 2021

A nematode infection can become severe and deadly with the use of corticosteroids

Healthcare workers in tropical and sub-tropical settings where strongyloidiasis is prevalent or caring for patients who have travelled to such areas, need to maintain a high level of awareness about the use of corticosteroids, including when this class of anti-inflammatories is given to patients suspected of infection with SARS-CoV-2.

19 Dec 2021

Efficacy of SARS-CoV2 variant-specific replicating RNA vaccines on SARS-CoV-2 variants of concern

A new study evaluates the repRNA vaccine expressing the SARS-CoV-2 spike protein for the B.1.1.7 and B.1.351 variants in mice and hamsters.

19 Dec 2021

CRISPR-based microfluidic platform detects respiratory viruses and SARS-CoV-2 variants

Researchers in the US have developed a novel multiplexed diagnostic platform based on CRISPR-based approaches and microfluidics - enabling robust and simultaneous surveillance of multiple viruses and viral variants. Currently, the paper is available on the medRxiv* preprint server pending peer review.

19 Dec 2021

Production of functional SARS-CoV-2 spike protein in single-cell green alga

A new study uses a novel algal platform for the generation of the SARS-CoV-2 spike protein.

19 Dec 2021

Study says COVID mRNA-based vaccines best for booster vaccination

A new study looks at the adaptive immune response to COVID-19 vaccines, wherein the authors compare heterologous to homologous immunization.

19 Dec 2021

Echinacea purpurea may help prevent respiratory tract infections during COVID-19 pandemic

A new study describes the results of using an extract of the medicinal plant Echinacea purpurea to treat non-severe cases of COVID-19.

19 Dec 2021

A class of FDA-approved drugs can effectively stop aggressive uterine cancer

A team of scientists led by the University of Michigan Health Rogel Cancer Center has found that a class of U.S. Food and Drug Administration-approved drugs can effectively stop a highly aggressive type of uterine cancer in its tracks, paving a quick path toward new treatment strategies for a deadly cancer with limited therapeutic options.

17 Dec 2021

Government and faith leaders unite in the national effort to urge booster uptake

The government and faith leaders have united in the national effort to get the country boosted in the wake of a surge in Omicron cases.

17 Dec 2021

Investigating potential cross-protection against SARS-CoV-2 after previous exposure to bovine coronavirus

Researchers have conducted an investigation to probe the similarity of viral epitopes between bovine coronavirus (BCoV) and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

17 Dec 2021

Primary responses to SARS-CoV-2 in COVID-19 naïve vaccinees

Researchers evaluated primary responses in SARS-CoV-2-naïve vaccinees, as well as secondary responses in the SARS-CoV-2-infected vaccines, and observed a clear set of differences in their clinical symptoms, antibody levels, and cellular and mucosal immune responses.

17 Dec 2021

WHO supports Nigeria in responding to the yellow fever outbreak amidst a global pandemic

In early November 2020, positive samples for yellow fever were reported from five Nigerian states. Nigeria is a high-risk country for yellow fever and is a priority country for the global eliminate yellow fever epidemics (EYE) strategy.

17 Dec 2021

As hospitals fill up, paramedics spend more time moving patients, less on emergencies

The night after Thanksgiving, a small ambulance service that covers a huge swath of southwestern Colorado got a call that a patient needed an emergency transfer from the hospital in Gunnison to a larger one with an intensive care unit 65 miles away in Montrose.

17 Dec 2021

Impact of SARS-CoV-2 Omicron mutations on the use of therapeutic antibodies in COVID-19 treatment

Researchers investigated the mutations reported in the Omicron variant and its likely impact on the use of therapeutic antibodies in COVID-19 treatment as well as on vaccinated individuals.

17 Dec 2021

R-Biopharm receives approval of COVID-19 test in the UK under CTDA legislation

R-Biopharm announces that the company’s RIDA®GENE Flu & SARS-CoV-2 multiplex test (PG6825) has been approved in the UK under the UK Health Security Agency’s Medical Devices (Coronavirus Test Device Approvals) Regulations 2021 (“CTDA”).

17 Dec 2021

Analysis of the alteration of neutralizing titers with Omicron pseudovirus

A new study measured antibody levels from blood samples of vaccinated individuals and individuals who recovered from COVID-19 illness.

17 Dec 2021

COVID-19 variant that caused cough as first symptom may have hastened disease spread in the U.S.

The strain of COVID-19 virus that was circulating in the United States and Europe during the first wave of the pandemic may have been particularly infectious because the most common first symptom was likely a cough, according to a study led by researchers from the USC Dornsife College of Letters, Arts and Science.

16 Dec 2021

Study provides a more effective treatment approach to preventing graft-versus-host-disease

A new study led by UC Davis Health researchers showed that blocking IL-6 and TNF cytokines provides a more effective approach to preventing life-threatening graft-versus-host-disease (GVHD), an inflammatory condition that develops in patients after their allogeneic hematopoietic stem cell transplantation (allo-HSCT).

16 Dec 2021

Virus News and Research

Latest Virus News and Research

Impact of SARS-CoV-2 variants in unvaccinated and vaccinated U.S. military personnel

Humanized mice reveals why few COVID-19 cases are more severe than others

REACT-1 study shows COVID boosters and first doses in children are providing important protection

A nematode infection can become severe and deadly with the use of corticosteroids

Efficacy of SARS-CoV2 variant-specific replicating RNA vaccines on SARS-CoV-2 variants of concern

CRISPR-based microfluidic platform detects respiratory viruses and SARS-CoV-2 variants

Production of functional SARS-CoV-2 spike protein in single-cell green alga

Study says COVID mRNA-based vaccines best for booster vaccination

Echinacea purpurea may help prevent respiratory tract infections during COVID-19 pandemic

A class of FDA-approved drugs can effectively stop aggressive uterine cancer

Government and faith leaders unite in the national effort to urge booster uptake

Investigating potential cross-protection against SARS-CoV-2 after previous exposure to bovine coronavirus

Primary responses to SARS-CoV-2 in COVID-19 naïve vaccinees

WHO supports Nigeria in responding to the yellow fever outbreak amidst a global pandemic

As hospitals fill up, paramedics spend more time moving patients, less on emergencies

Impact of SARS-CoV-2 Omicron mutations on the use of therapeutic antibodies in COVID-19 treatment

R-Biopharm receives approval of COVID-19 test in the UK under CTDA legislation

Analysis of the alteration of neutralizing titers with Omicron pseudovirus

COVID-19 variant that caused cough as first symptom may have hastened disease spread in the U.S.

Study provides a more effective treatment approach to preventing graft-versus-host-disease

A new way of characterising biomolecules eBook

Exploring the role of confocal-based high-content imaging in advancing core facilities

Transforming Cardiovascular Care: Insights from Mina Makar at AstraZeneca

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Virus News and Research

Latest Virus News and Research

A new way of characterising biomolecules eBook

Exploring the role of confocal-based high-content imaging in advancing core facilities

Transforming Cardiovascular Care: Insights from Mina Makar at AstraZeneca

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Newsletters you may be interested in